/Investor DB

Consensus Business Group — 2025 Investments

5 investments dated 2025 · listed companies and verified rows first · show all

Arcuro Medicalarcuromedical.cominJan 2025

Arcuro Medical develops all-suture soft-tissue repair technologies for orthopedic surgeons, with its flagship SuperBall® System providing knotless fixation for meniscal and rotator cuff procedures.

HealthtechMedical Devices

Co-investorsTrendlines GroupVarana

Escala Medicalescalamedical.cominJul 2025

Escala Medical develops advanced medical devices for pelvic organ prolapse repair, targeting women seeking to restore quality of life.

FemTechHealthtechMedical Devices

Edit Goldberg(CEO)in

Co-investorsTrendlines Group

Ibi Agibi-ag.cominFeb 2025

IBI-Ag develops selective bio-insecticides based on single domain antibody technology that target specific proteins in insect pests, aimed at helping farmers protect crops with minimal harm to workers, consumers, and the environment.

AgTechBiotechFoodTech

Rony Oren Benaroya(Founder & Chief Technology Officer)inAmir Ayali(Founder & Scientific Advisor)inArnon Heyman(Chief Executive Officer)in

Co-investorsFirst Imagine!Trendlines GroupBandera CapitalIsrael Innovation Authority

Synchrony MedicalinAug 2025

BiotechJersey City, US

Anat Shani(Executive Officer, Director)in

BoardKevin Kotler(Director)Eileen Ke(Director)Elad Dushack(Director)Shai Policker(Director)

Co-investorsNew Jersey Economic Development Authority

The Trendlines Grouptrendlines.comin𝕏Nov 2025

Trendlines Group is an Israeli public company listed on Singapore Exchange that invests in and supports portfolio companies.

AgTechFoodTechMedical DevicesSector AgnosticMisgav, IL

David Todd Dollinger(CEO and Chair of the Board)Stephen Louis Rhodes(CEO and Chair of the Board)

Co-investorsPix Vine CapitalBandera Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.